Functional characterization of Orientia tsutsugamushi ankryin repeat proteins
恙虫病东方体锚蛋白重复蛋白的功能表征
基本信息
- 批准号:8355882
- 负责人:
- 金额:$ 7.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-05-01 至 2014-04-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAffinity ChromatographyAfghanistanAnaplasma phagocytophilumAnkyrin RepeatAntibiotic ResistanceAntibioticsApplications GrantsAsiaBacteriaBiologicalCase StudyCell physiologyCellsChiggersCoiled-Coil DomainDiseaseDisease OutbreaksEffectivenessEukaryotic CellFeverFundingGenesGenomeGlutathione S-TransferaseGoalsGrantHourIn VitroInfectionJapanKnowledgeLigandsLocalesLocationMammalian CellMarinesMediatingMilitary PersonnelMitesMolecularNative-BornNatureOrientia tsutsugamushiPakistanPathogenesisPathway interactionsPatternPrecipitationPrevalenceProteinsRecombinantsReportingRickettsialesRiskRoleScrub TyphusSoldierStagingStressTestingTherapeuticTrainingViralVisitWorkbasedesignexperienceglobal healthin vivoinhibitor/antagonistinterestmortalitynoveloverexpressionpathogenprotein protein interactionsmall moleculesuccesstraffickingtyphus vaccine
项目摘要
DESCRIPTION (provided by applicant): Scrub typhus is a potentially fatal disease that is endemic in the Asia-Pacific region, where 1 billion people are at risk for infection and 1 million new cases are reported annually. Scrub typhus is treatable with antibiotics, but reinfections are common and decreased efficacy of antibiotics has been increasingly reported. A recent outbreak among U.S. Marines training at a military base in Japan, and the prevalence of scrub typhus in Afghanistan and Pakistan where U.S. troops are deployed, echoes the risk of U.S. soldiers for the disease. The etiologic agent is the trombiculid mite-transmitted obligate intracellular bacterium, Orientia tsutsugamushi. Despite the global health threat that it poses, O.
tsutsugamushi is severely understudied. Indeed, how this pathogen manipulates eukaryotic host cell functions to facilitate its intracellular survival is poorly understood. An emerging theme among many intracellular bacterial pathogens is that they translocate ankryin repeat-containing proteins (Anks) into eukaryotic host cells. The ankryin repeat is one of the most common protein-protein interaction motifs in nature. Anks of other bacterial and viral pathogens traffic t distinct subcellular locations where they interact with host target proteins and mimic or interfere
with host cell functions to facilitate pathogen survival. The O. tsutsugamushi genome carries 38 ank genes, and we have determined that all 38 are expressed during infection of mammalian host cells in vitro. Genes encoding Ank4, Ank9, and Ank12_1 are induced at 1 h post-infection, Ank6 at 4 h, and Ank13 at 8 h. We hypothesize that Ank4, Ank6, Ank9, Ank12_1, and Ank13 are important for O. tsutsugamushi to establish infection and have prioritized these proteins for functional studies. Genes encoding ank1, ank5, and ank17 are also expressed during infection and carry coiled-coil domains. The coiled-coil domain is a signature protein-protein interaction motif of numerous bacterial pathogen effectors that mediates interaction with host cell targets. Because Ank1, Ank5, and Ank17 carry both ankyrin repeat and coiled-coil motifs, we will include them in our functional studies. In Aim 1, we will assess if the eight Anks of interest perform distinct effector functions by ectopically expressing the proteins in mammalian host cells and identifying the subcellular locations to which they traffic. To determine if they interact with hos cell factors that are critical for O. tsutsugamushi intracellular survival, we will assess whether ectopically expressed Anks competitively inhibit Orientia survival. In Aim 2, we will capture and identify host cell target proteins that interact with Orientia Anks using in vivo coprecipitation ad affinity chromatography. The proposed work will fill a considerable knowledge gap of how an understudied pathogen of global biomedical importance facilitates its intracellular survival. Since
antibiotic resistance among O. tsutsugamushi isolates is increasing and reinfections are common, defining the functional roles of Anks will potentially aid the design of small molecule inhibitors that target specific Anks to treat scrub typhus.
PUBLIC HEALTH RELEVANCE: Scrub typhus is a potentially deadly disease that afflicts 1 million people annually in the Asia-Pacific region. One billion people - the indigenous population
that lives in, U. S. Military personnel that are serving in, and travelers that visit this region are at risk for infection. Reports of decreased effectiveness of antibiotics against the scrub typhus bacterium stress the need for a scrub typhus vaccine. This project will dissect how the causative agent facilitates its survival inside mammalian host cells as a key first step in developing novel and efficacious means for treating scrub typhus.
描述(由申请人提供):恙虫病是一种潜在的致命疾病,在亚太地区流行,有10亿人面临感染风险,每年报告100万例新病例。恙虫病可以用抗生素治疗,但再感染很常见,越来越多的报道称抗生素的疗效下降。最近在日本一个军事基地训练的美国海军陆战队爆发疫情,以及在部署美军的阿富汗和巴基斯坦流行的丛林斑疹伤寒,都反映了美国士兵感染这种疾病的风险。病原体是恙螨传播的专性细胞内细菌,恙虫病东方体。尽管它对全球健康构成威胁,O。
对恙虫病的研究严重不足。事实上,这种病原体如何操纵真核宿主细胞的功能,以促进其细胞内的生存知之甚少。许多细胞内细菌病原体中的一个新兴主题是它们将含锚蛋白重复序列的蛋白(Anks)转运到真核宿主细胞中。锚蛋白重复序列是自然界中最常见的蛋白质相互作用基序之一。其他细菌和病毒病原体的锚在不同的亚细胞位置与宿主靶蛋白相互作用,并模仿或干扰
具有促进病原体存活的宿主细胞功能。手术恙虫病基因组携带38个ANK基因,我们已经确定所有38个ANK基因在体外感染哺乳动物宿主细胞时表达。在感染后1小时诱导编码Ank 4、Ank 9和Ank12_1的基因,在4小时诱导编码Ank 6的基因,并且在8小时诱导编码Ank 13的基因。我们假设Ank 4、Ank 6、Ank 9、Ank12_1和Ank 13对O.恙虫病建立感染,并优先考虑这些蛋白质的功能研究。编码ank 1、ank 5和ank 17的基因也在感染过程中表达,并携带卷曲螺旋结构域。卷曲螺旋结构域是介导与宿主细胞靶标相互作用的许多细菌病原体效应物的标志性蛋白质-蛋白质相互作用基序。由于Ank 1、Ank 5和Ank 17同时携带锚蛋白重复序列和卷曲螺旋基序,因此我们将其纳入功能研究。在目标1中,我们将评估八个感兴趣的Anks是否通过在哺乳动物宿主细胞中异位表达蛋白质并鉴定它们运输的亚细胞位置来执行不同的效应器功能。为了确定它们是否与对O.为了提高恙虫病细胞内存活率,我们将评估异位表达的Anks是否竞争性抑制东方体存活。在目标2中,我们将使用体内共沉淀和亲和层析来捕获和鉴定与东方体Anks相互作用的宿主细胞靶蛋白。拟议的工作将填补一个相当大的知识空白,如何研究全球生物医学重要性的病原体促进其细胞内生存。以来
O.随着恙虫病分离株的增加和再感染的普遍,确定Anks的功能作用将可能有助于设计靶向特定Anks的小分子抑制剂来治疗恙虫病。
公共卫生相关性:丛林斑疹伤寒是一种潜在的致命疾病,每年在亚太地区影响100万人。 10亿人-土著人口
它生活在美国。S. 在该地区服役的军事人员和访问该地区的旅行者都有感染的风险。 针对恙虫病细菌的抗生素有效性降低的报告强调了对恙虫病疫苗的需要。 这个项目将剖析病原体如何促进其在哺乳动物宿主细胞内的生存,作为开发治疗恙虫病的新的和有效的手段的关键的第一步。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jason A Carlyon其他文献
Jason A Carlyon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jason A Carlyon', 18)}}的其他基金
Orientia tsutsugamushi Ank-host interactions in scrub typhus pathogenesis
恙虫病东方体在恙虫病发病机制中的Ank-宿主相互作用
- 批准号:
10413474 - 财政年份:2022
- 资助金额:
$ 7.48万 - 项目类别:
Orientia tsutsugamushi Ank-host interactions in scrub typhus pathogenesis
恙虫病东方体在恙虫病发病机制中的Ank-宿主相互作用
- 批准号:
10571846 - 财政年份:2022
- 资助金额:
$ 7.48万 - 项目类别:
Functional characterization of an Orientia tsutsugamushi nucleomodulin
恙虫病东方体核调节素的功能表征
- 批准号:
10117190 - 财政年份:2020
- 资助金额:
$ 7.48万 - 项目类别:
Defining the pathobiological roles of Orientia tsutsugamushi Ank proteins
确定恙虫病东方体 Ank 蛋白的病理生物学作用
- 批准号:
10455792 - 财政年份:2017
- 资助金额:
$ 7.48万 - 项目类别:
Rickettsiales: Host-Vector-Pathogen Interactions
立克次体:宿主-载体-病原体相互作用
- 批准号:
9193259 - 财政年份:2016
- 资助金额:
$ 7.48万 - 项目类别:
Orientia tsutsugamushi modulation of host cell ubiquitination machinery
恙虫病东方体对宿主细胞泛素化机制的调节
- 批准号:
8720687 - 财政年份:2013
- 资助金额:
$ 7.48万 - 项目类别:
Anaplasma phagocytophilum hijacking of host cell monoubiquitination
嗜吞噬细胞无形体劫持宿主细胞单泛素化
- 批准号:
8784189 - 财政年份:2013
- 资助金额:
$ 7.48万 - 项目类别:
Anaplasma phagocytophilum hijacking of host cell monoubiquitination
嗜吞噬细胞无形体劫持宿主细胞单泛素化
- 批准号:
8637532 - 财政年份:2013
- 资助金额:
$ 7.48万 - 项目类别:
Orientia tsutsugamushi modulation of host cell ubiquitination machinery
恙虫病东方体对宿主细胞泛素化机制的调节
- 批准号:
8427914 - 财政年份:2013
- 资助金额:
$ 7.48万 - 项目类别:
The roles of Anaplasma phagocytophilum surface proteins in cellular invasion
嗜吞噬细胞无形体表面蛋白在细胞侵袭中的作用
- 批准号:
8510769 - 财政年份:2012
- 资助金额:
$ 7.48万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 7.48万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 7.48万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 7.48万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 7.48万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 7.48万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 7.48万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 7.48万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 7.48万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 7.48万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 7.48万 - 项目类别:
Operating Grants